IRLAB Therapeutics AB (publ)

OM:IRLAB A Stock Report

Market Cap: SEK 804.0m

IRLAB Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

OM:IRLAB A Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
21 May 24BuySEK 62,200Carola LemneIndividual4,000SEK 15.55
21 May 24BuySEK 122,400Catharina WallichIndividual8,000SEK 15.30
14 May 24BuySEK 31,000Gunnar OlssonIndividual2,000SEK 15.50
13 May 24BuySEK 68,037Viktor SiewertzIndividual5,000SEK 13.61
10 May 24BuySEK 259,680Daniel JohnssonIndividual20,000SEK 12.98

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of IRLAB A?
Owner TypeNumber of SharesOwnership Percentage
Private Companies7,040,05413.6%
Individual Insiders11,568,53822.3%
Institutions12,998,26225.1%
General Public20,261,55239.1%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 60.71% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.43%
Avanza Fonder AB
4,893,580SEK 75.9m0%0.06%
8.71%
Daniel Johnsson
4,520,000SEK 70.1m0%no data
7.38%
Ancoria Insurance Public Ltd., Asset Management Arm
3,826,638SEK 59.3m0%100.0%
7.07%
FV Group AB
3,665,626SEK 56.8m0%no data
6.74%
Fourth Swedish National Pension Fund (AP4)
3,495,420SEK 54.2m0%0.02%
2.92%
Philip Diklev
1,517,106SEK 23.5m0%no data
2.33%
Marinvest Holding AB
1,208,250SEK 18.7m0%no data
1.54%
Baretten Invest AB
800,000SEK 12.4m0%no data
1.46%
Clas Sonesson
757,535SEK 11.7m0%no data
1.44%
Nicholas Waters
745,146SEK 11.5m0%no data
1.34%
Lars-Erik Olsson
695,000SEK 10.8m0%no data
1.22%
Susanna Waters
631,367SEK 9.8m0%no data
1.22%
Joakim Tedroff
631,367SEK 9.8m0%no data
1.18%
Claes Sandesjö
612,954SEK 9.5m0%no data
1.02%
Vic Tor AB
530,636SEK 8.2m0%no data
1.01%
Hans Victor
522,063SEK 8.1m0%no data
0.87%
Galba Holding AB
450,000SEK 7.0m0%no data
0.74%
Bassholmen Aktiebolag
385,542SEK 6.0m0%no data
0.7%
Cecilia Stenberg
365,210SEK 5.7m0%no data
0.57%
Handelsbanken Asset Management
294,684SEK 4.6m0%no data
0.5%
Peder Svensson
261,925SEK 4.1m0%no data
0.48%
SEB Investment Management AB
251,161SEK 3.9m0%no data
0.46%
Viktor Siewertz
238,965SEK 3.7m0%no data
0.25%
FCG Fonder AB
131,617SEK 2.0m0%0.02%
0.12%
Storebrand Fonder AB,
60,000SEK 930.0k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/20 14:59
End of Day Share Price 2025/01/17 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

IRLAB Therapeutics AB (publ) is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Gonzalo Artiach CastanonABG Sundal Collier Sponsored
null nullABG Sundal Collier Sponsored
Soo RomanoffEdison Investment Research